Figure 3From: Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trialThe incidence of renal disease progression during the follow-up period. *p = 0.022 and **p = 0.003 for the TwHF and valsartan groups, respectively.Back to article page